Intentar ORO - Gratis
Venturi Partners Launches Fund 2, Targets $250 Mn
Mint Mumbai
|March 20, 2025
Venturi had in April 2022 raised $180 million from prominent families in Europe and Asia for its first fund
Venturi Partners, a growth-stage consumer-focused investor in India and Southeast Asia, has launched its second fund, targeting a corpus of $225-250 million. The Singapore-based firm has backed a host of consumer companies in India, including Country Delight, Livspace, K-12 Techno, and Pickup Coffee.
Its second fund will target high-growth sectors such as retail, education, healthcare, and fast-moving consumer goods (FMCG), with a continued focus on India and Southeast Asia.
Esta historia es de la edición March 20, 2025 de Mint Mumbai.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint Mumbai
Mint Mumbai
The cost of convenience for tap-to-book domestic help
Frequent change of helpers, surge pricing and slot shortages remain key pain points for users
3 mins
May 14, 2026
Mint Mumbai
Billboard has kept humans off its charts before: why not AI?
This tracker of musical hits must show how discerning it really is
3 mins
May 14, 2026
Mint Mumbai
Flex-fuel vehicle plan caught in dilemma
The government's push for flex-fuel vehicle rollout is facing a classic chicken-and-egg stalemate.
2 mins
May 14, 2026
Mint Mumbai
Hollywood retreats but Cannes thrives
Cannes has grown as a breeding ground for genuine Oscar contenders
2 mins
May 14, 2026
Mint Mumbai
Dixon’s stumble is a test for electronics manufacturers
Dixon Technologies’ consolidated revenues rose by just 2% year-on-year in the March quarter (Q4FY26) to ₹10,511 crore, the same as Q3’s growth rate.
1 mins
May 14, 2026
Mint Mumbai
The taste of summer in a platter of aamras-puri
Hand-pressed pulp of Hapus, Payri and Kesar mango varieties is being tinned, and turned into modern desserts
4 mins
May 14, 2026
Mint Mumbai
Cipla builds biosimilars pipeline as profit dips in 2025-26
Cipla is building a biosimilars pipeline, and aims to steadily add products over five years, its top executive said, as the company bets on the fast-growing market for cheaper versions of complex biologic drugs.
1 min
May 14, 2026
Mint Mumbai
Skyroot ties founder Esops to rocket launch milestones
The homegrown space-tech startup recently raised $60 million at a valuation of $1.1 billion
2 mins
May 14, 2026
Mint Mumbai
Zydus buys US cancer drug maker Assertio
Zydus Lifesciences said on Wednesday that it will acquire Nasdaq-listed pharmaceutical company Assertio Holdings for $166.4 million in an all-cash deal via its subsidiary. Assertio focuses on specialty and oncology supportive-care therapy.
1 min
May 14, 2026
Mint Mumbai
Air India slashes global flights as fuel costs, airspace curbs bite
Air India plans to operate around 37% fewer international flights between June and August compared with April, as prolonged airspace restrictions and soaring aviation fuel prices amid the West Asia war weigh on their viability.
1 mins
May 14, 2026
Listen
Translate
Change font size
